Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long QT Syndrome: A Case Report

Vortioxetine Can Be Used Safely to Treat Depression After Implantable Cardioverter Defibrillator Implantation for Congenital Long QT Syndrome: A Case Report

ABSTRACT Background Vortioxetine, an antidepressant, acts on multiple 5‐hydroxytryptamine receptors in addition to inhibiting the 5‐hydroxytryptamine transporter. Currently, data on the effect of vortioxetine on the QT interval are limited. To the best of our knowledge, whether vortioxetine can safe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Makio Yamauchi, Koji Otsuki, Kouhei Sato, Michiharu Nagahama, Junya Tanabe, Masatoshi Inagaki
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Neuropsychopharmacology Reports
Subjects:	congenital long QT syndrome depression implantable cardioverter defibrillator QT prolongation vortioxetine
Online Access:	https://doi.org/10.1002/npr2.70017
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short QT interval syndrome
by: I. G. Fomina, et al.
Published: (1970-01-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

Battery Longevity in Modern Implantable Cardioverter‐Defibrillators and Cardiac Resynchronization Therapy‐Defibrillators
by: Kotaro Nishino, et al.
Published: (2025-08-01)

Congenital Long QT Syndrome: A Focus on Risk Stratification and Management
by: Deepti Ranganathan, et al.
Published: (2025-06-01)

Depression and Implantable Cardioverter‐Defibrillator Implantation in Black Patients at Risk for Sudden Cardiac Death
by: Brian C. Boursiquot, et al.
Published: (2024-07-01)

Utility of key anatomical landmarks visualization using a radiopaque tape for successful extravascular implantable cardioverter defibrillator implantation
by: Satoshi Oka, et al.
Published: (2025-06-01)

Factors associated with the risk of progression and decompensation of heart failure in patients with an implantable cardioverter-defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-04-01)

Appropriate implantable cardioverter-defibrillator therapy triggered by heat stroke
by: Carlos Fernando Paz Mamani, et al.
Published: (2025-01-01)

Prolonged QT Syndrome Presenting as Epilepsy
by: J Gordon Millichap
Published: (1994-09-01)

Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01)

A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease
by: Т. A. Atabekov, et al.
Published: (2019-04-01)

Safety and Tolerability of Implanted Subcutaneous Cardioverter-Defibrillator Systems
by: A. V. Vereshchagina, et al.
Published: (2022-09-01)

Association Between Disturbed Serum Phosphorus Levels and QT Interval Prolongation
by: Sho Sasaki, et al.
Published: (2024-06-01)

Predictors of Shock‐Reduction Programming and Its Impact on Implantable Cardioverter‐Defibrillator Therapies and Mortality: The CERTITUDE Registry
by: Sebastian E. Beyer, et al.
Published: (2024-08-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)

Syncope and QT Prolongation Associated with the Use of Herbal Product and m-RNA Vaccination in a Young Woman
by: Osman Pirhan, et al.
Published: (2023-01-01)

Clinical outcomes during and after wearable cardioverter defibrillator use in Japanese patients with heart failure: A single‐center experience
by: Noriko Kikuchi, et al.
Published: (2024-12-01)

Potential QT-prolonging drug-drug interactions in cardiovascular disease patients
by: Milena Kovačević, et al.
Published: (2025-01-01)

Implantable cardioverter defibrillator: decision-making on turning off in patients with end-stage heart failure
by: V. K. Lebedeva, et al.
Published: (2020-09-01)

Biomarkers in predicting mortality from cardiovascular events in patients with heart failure and an implanted cardioverter-defibrillator
by: N. N. Ilov, et al.
Published: (2023-10-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01)

External validation of a multivariate model for predicting the risk of death in patients with chronic heart failure and an implantable cardioverter – defibrillator
by: N. B. Lebedeva, et al.
Published: (2024-07-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Cardiac function evaluation in healthy volunteers and patients with implantable cardioverter-defibrillators using high-bandwidth spoiled gradient-echo cine
by: Calder D. Sheagren, et al.
Published: (2025-01-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
by: Sidhi Laksono Purwowiyoto, et al.
Published: (2024-10-01)

URGENT CATHETER ABLATION OF THE ELECTRICAL STORM IN PATIENTS WITH IMPLANTED CARDIOVERTER-DEFIBRILLATOR
by: R. B. Tatarsky, et al.
Published: (2015-11-01)

Reducing fluoroscopy time during cardioverter-defibrillator implantation, performed with considering of myocardium perfusion scintigraphy results in patients with coronary artery disease
by: T. A. Atabekov, et al.
Published: (2018-12-01)

CRO-INSIGHT: Utilization of Implantable Cardioverter Defibrillators in Non-ischemic and Ischemic Cardiomyopathy in a Single Croatian Tertiary Hospital Centre
by: Mislav Puljevic, et al.
Published: (2025-04-01)

Long-term outcomes of cardiac resynchronization therapy and implantable cardioverter defibrillators in elderly patients with heart failure
by: Yanxiao Su, et al.
Published: (2025-06-01)

Comparative analysis of implantable cardioverter-defibrillator efficacy in ischemic and non-ischemic cardiomyopathy in patients with heart failure
by: Emre Demir, et al.
Published: (2025-07-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Analysis of arrhythmic episodes in patients with implanted cardioverter defibrillators and a high risk of sudden cardiac death
by: A. S. Postol, et al.
Published: (2019-11-01)

Mitochondrial DNA Polymorphisms of Peripheral Blood Mononuclear Cells Associated with Sustained Ventricular Tachycardia in Patients with Cardioverter-Defibrillator Implantation Indications
by: Tariel Atabekov, et al.
Published: (2025-03-01)

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator
by: Mohammad Abumayyaleh, et al.
Published: (2025-04-01)

MAGNESIUM PREPARATIONS IN PREVENTING ARRHYTHMIAS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
by: A. M. Shilov, et al.
Published: (2002-02-01)